Rostom M. Ramasamy R. Kohn T.P.

History of testosterone therapy through the ages.

Int J Impot Res. https://doi.org/10.1038/s41443-021-00493-w

Molecular Mechanisms of Androgen Action – A Historical Perspective.

in: Saatcioglu F. Androgen action - methods and Protocols. Springer, New York: 3-24Nieschlag E. Nieschlag S.

Testosterone deficiency: a historical perspective.

Asian J Androl. 16: 161-168

The effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals.

Lancet. 134: 105-107Cussons A.J. Bhagat C.I. Fletcher S.J. et al.

Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment.

Med J Aust. 177: 678-679Rao P.K. Boulet S.L. Mehta A. et al.

Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States.

J Urol. 197: 1121-1126Zhou C.K. Advani S. Chaloux M. et al.

Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.

J Urol. 203: 1184-1190Anawalt B.D. Braunstein G.D.

Testes.

in: Gardner D.G. Shoback D. Greenspan's Basic and Clinical Endocrinology, 10e. McGraw-Hill Education, New York, NYWhite B.A. Harrison J.R. Mehlmann L.M.

The Male Reproductive System.

in: Endocrine and reproductive Physiology. Elsevier, St. Louis: 186-203Zirkin B.R. Papadopoulos V.

Leydig cells: formation, function, and regulation.

Biol Reprod. 99: 101-111Hammond G.L. Ruokonen A. Kontturi M. et al.

The simultaneous radioimmunoassay of seven steroids in human spermatic and peripheral venous blood.

J Clin Endrocrinology Metab. 45: 16-24Skorupskaite K. George J.T. Anderson R.A.

The kisspeptin-GnRH pathway in human reproductive health and disease.

Hum Reprod Update. 20: 485-500Harter C.J.L. Kavanagh G.S. Smith J.T.

The role of kisspeptin neurons in reproduction and metabolism.

J Endocrinol. 238: R173-R183Kaprara A. Huhtaniemi I.T.

The hypothalamus-pituitary-gonad axis: Tales of mice and men.

Metabolism. 86: 3-17

Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.

Front Neuroendocrinol. 35: 197-220Matsumoto A.M. Anawalt B.D.

Testicular Disorders.

in: Melmed S. Williams Textbook of endocrinology. 14th edition. Elsevier, Philadelphia: 668-755Munell F. Suarez-Quian C.A. Selva D.M. et al.

Androgen-binding protein and reproduction: where do we stand?.

J Androl. 23: 598-609

Assessment of free testosterone concentration.

J Steroid Biochem Mol Biol. 190: 207-211Wan Q. Xie Y. Zhou Y. et al.

Research progress on the relationship between sex hormone-binding globulin and male reproductive system diseases.

Andrologia. 53: e13893Boeri L. Capogrosso P. Cazzaniga W. et al.

SHBG levels in primary infertile men: a critical interpretation in clinical practice.

Endocr Connect. 9: 658-666

Control of sex development.

Best Pract Res Clin Endocrinol Metab. 24: 163-186

Mini-puberty and true puberty: differences in testicular function.

Ann Endocrinol (Paris). 75: 58-63

Importance of the Androgen Receptor Signaling in Gene Transactivation and Transrepression for Pubertal Maturation of the Testis.

Cells. 8Kuiri-Hanninen T. Sankilampi U. Dunkel L.

Activation of the hypothalamic-pituitary-gonadal axis in infancy: minipuberty.

Horm Res Paediatr. 82: 73-80Rey R.A. Musse M. Venara M. et al.

Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis.

Microsc Res Tech. 72: 787-795

The Role of Androgen Signaling in Male Sexual Development at Puberty.

Endocrinology. 162Kloner R.A. Carson 3rd, C. Dobs A. et al.

Testosterone and Cardiovascular Disease.

J Am Coll Cardiol. 67: 545-557Blaya R. Blaya P. Rhoden L. et al.

Low Testosterone Levels and Metabolic Syndrome in Aging Male.

Curr Pharm Des. 23: 4470-4474Stamatiades G.A. Kaiser U.B.

Gonadotropin regulation by pulsatile GnRH: Signaling and gene expression.

Mol Cell Endocrinol. 463: 131-141

The relationship between sleep disorders and testosterone in men.

Asian J Androl. 16: 262-265

The relationship between sleep disorders and testosterone.

Curr Opin Endocrinol Diabetes Obes. 21: 239-243Smith R.P. Coward R.M. Kovac J.R. et al.

The evidence for seasonal variations of testosterone in men.

Maturitas. 74: 208-212Mulhall J.P. Trost L.W. Brannigan R.E. et al.

Evaluation and Management of Testosterone Deficiency: AUA Guideline.

J Urol. 200: 423-432Murray-Lyon I.M. Westaby D. Paradinas F.

Hepatic complications of androgen therapy.

Gastroenterology. 73: 1461

Further experiments on the administration of hormones by the subcutaneous implantation of tablets.

Lancet. 2: 606-609Barbonetti A. D'Andrea S. Francavilla S.

Testosterone replacement therapy.

Andrology. 8: 1551-1566

Transdermal testosterone delivery: testosterone patch and gel.

World J Urol. 21: 316-319

Testosterone Replacement Therapy in Hypogonadal Men.

Endocrinol Metab Clin North Am. 51: 77-98

The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Cancer Res. 1: 293-297

Androgen Deprivation Therapy and Secondary Hormone Therapy in the Management of Hormone-sensitive and Castration-resistant Prostate Cancer.

Urology. 86: 852-861Lowrance W.T. Breau R.H. Chou R. et al.

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.

J Urol. 205: 14-21Lowrance W.T. Breau R.H. Chou R. et al.

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.

J Urol. 205: 22-29

Androgen deprivation therapy: indications, methods of utilization, side effects, and their management.

Can J Urol. 27: 11-16Tilley W.D. Marcelli M. Wilson J.D. et al.

Characterization and expression of a cDNA encoding the human androgen receptor.

Proc Natl Acad Sci USA. 86: 327-331

Androgen Receptor Structure, Function and Biology: From Bench to Bedside.

Clin Biochem Rev. 37MacLean H.E. Warne G.L. Zajac J.D.

Localization of Functional Domains in the Androgen Receptor.

J Steroid Biochem Mol Biol. 62: 233-242Palazzolo I. Gliozzi A. Rusmini P. et al.

The role of the polyglutamine tract in androgen receptor.

J Steroid Biochem Mol Biol. 108: 245-253

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor.

Expert Opin Drug Discov. 15: 551-560Geserick C. Meyer H.A. Haendler B.

The role of DNA response elements as allosteric modulators of steroid receptor function.

Mol Cell Endocrinol. 236: 1-7Clinckemalie L. Vanderschueren D. Boonen S. et al.

The hinge region in androgen receptor control.

Mol Cell Endocrinol. 358: 1-8Steketee K. Berrevoets C.A. Dubbink H.J. et al.

Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor.

Eur J Biochem. 269: 5780-5791McPhaul M.J. Marcelli M. Zoppi S. et al.

Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.

J Clin Invest. 90: 2097-2101Agoulnik I.U. Weigel N.L.

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

J Cell Biochem. 99: 362-372

Prostate specific antigen gene regulation by androgen receptor.

J Cell Biochem. 93: 233-241

Androgen receptor signaling in prostate cancer.

Cancer Metastasis Rev. 33: 413-427

Androgen receptor signaling and mutations in prostate cancer.

Asian J Androl. 12: 639-657

Dysregulated androgen synthesis and anti-androgen resistance in advanced prostate cancer.

Am J Clin Exp Urol. 9: 292-300Yuan X. Cai C. Chen S. et al.

Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis.

Oncogene. 33: 2815-2825

Nonclassical androgen and estrogen signaling is essential for normal spermatogenesis.

Semin Cell Dev Biol. 121: 71-81Deng Q. Zhang Z. Wu Y. et al.

Non-Genomic Action of Androgens is Mediated by Rapid Phosphorylation and Regulation of Androgen Receptor Trafficking.

Cell Physiol Biochem. 43: 223-236Darolutamide Aragon-Ching JB.

a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer.

Asian J Androl. 22: 76-78Rice M.A. Malhotra S.V. Stoyanova T.

Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer.

Front Oncol. 9: 801Schmidt K.T. Huitema A.D.R. Chau C.H. et al.

Resistance to second-generation androgen receptor antagonists in prostate cancer.

Nat Rev Urol. 18: 209-226Rajaram P. Rivera A. Muthima K. et al.

Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer.

Molecules. 25

Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer.

Cancer J. 19: 43-49Cooke P.S. Nanjappa M.K. Ko C. et al.

Estrogens in Male Physiology.

Physiol Rev. 97: 995-1043Schulster M. Bernie A.M. Ramasamy R.

The role of estradiol in male reproductive function.

Asian J Androl. 18: 435-440Lo E.M. Rodriguez K.M. Pastuszak A.W. et al.

Alternatives to Testosterone Therapy: A Review.

Sex Med Rev. 6: 106-113Fullhase C. Schneider M.P.

5-Alpha-Reductase Inhibitors and Combination Therapy.

Urol Clin North Am. 43: 325-336Wang K. Fan D.D. Jin S. et al.

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications.

Asian J Androl. 16: 274-279Uemura M. Tamura K. Chung S. et al.

Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.

Cancer Sci. 99: 81-86Swerdloff R.S. Dudley R.E. Page S.T. et al.

Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Endocr Rev. 38: 220-254van der Sluis T.M. Meuleman E.J. van Moorselaar R.J. et al.

Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.

BJU Int. 109: 183-188Bruchovsky N. Wilson J.D.

The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

J Biol Chem. 243: 2012-2021Wenderoth U.K. George F.W. Wilson J.D.

The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.

Endocrinology. 113: 569-573